These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 27609159)
1. Delayed onset of congenital hereditary endothelial dystrophy due to compound heterozygous SLC4A11 mutations. Kumawat BL; Gupta R; Sharma A; Sen S; Gupta S; Tandon R Indian J Ophthalmol; 2016 Jul; 64(7):492-5. PubMed ID: 27609159 [TBL] [Abstract][Full Text] [Related]
2. Fuchs Endothelial Corneal Dystrophy in a Heterozygous Carrier of Congenital Hereditary Endothelial Dystrophy Type 2 with a Novel Mutation in SLC4A11. Kim JH; Ko JM; Tchah H Ophthalmic Genet; 2015; 36(3):284-6. PubMed ID: 24502824 [TBL] [Abstract][Full Text] [Related]
3. Congenital Corneal Endothelial Dystrophies Resulting From Novel De Novo Mutations. Cunnusamy K; Bowman CB; Beebe W; Gong X; Hogan RN; Mootha VV Cornea; 2016 Feb; 35(2):281-5. PubMed ID: 26619383 [TBL] [Abstract][Full Text] [Related]
4. Coexistence of Congenital Hereditary Endothelial Dystrophy and Fuchs Endothelial Corneal Dystrophy Associated With SLC4A11 Mutations in Affected Families. Chaurasia S; Ramappa M; Annapurna M; Kannabiran C Cornea; 2020 Mar; 39(3):354-357. PubMed ID: 31714402 [TBL] [Abstract][Full Text] [Related]
6. Congenital hereditary endothelial dystrophy caused by SLC4A11 mutations progresses to Harboyan syndrome. Siddiqui S; Zenteno JC; Rice A; Chacón-Camacho O; Naylor SG; Rivera-de la Parra D; Spokes DM; James N; Toomes C; Inglehearn CF; Ali M Cornea; 2014 Mar; 33(3):247-51. PubMed ID: 24351571 [TBL] [Abstract][Full Text] [Related]
7. Mutational spectrum of the SLC4A11 gene in autosomal recessive congenital hereditary endothelial dystrophy. Sultana A; Garg P; Ramamurthy B; Vemuganti GK; Kannabiran C Mol Vis; 2007 Jul; 13():1327-32. PubMed ID: 17679935 [TBL] [Abstract][Full Text] [Related]
8. Mutations in sodium-borate cotransporter SLC4A11 cause recessive congenital hereditary endothelial dystrophy (CHED2). Vithana EN; Morgan P; Sundaresan P; Ebenezer ND; Tan DT; Mohamed MD; Anand S; Khine KO; Venkataraman D; Yong VH; Salto-Tellez M; Venkatraman A; Guo K; Hemadevi B; Srinivasan M; Prajna V; Khine M; Casey JR; Inglehearn CF; Aung T Nat Genet; 2006 Jul; 38(7):755-7. PubMed ID: 16767101 [TBL] [Abstract][Full Text] [Related]
9. SLC4A11 and the Pathophysiology of Congenital Hereditary Endothelial Dystrophy. Patel SP; Parker MD Biomed Res Int; 2015; 2015():475392. PubMed ID: 26451371 [TBL] [Abstract][Full Text] [Related]
10. Homozygous SLC4A11 mutation in a large Irish CHED2 pedigree. Hand CK; McGuire M; Parfrey NA; Murphy CC Ophthalmic Genet; 2017; 38(2):148-151. PubMed ID: 27057589 [TBL] [Abstract][Full Text] [Related]
11. Observation of nine previously reported and 10 non-reported Moazzeni H; Javadi MA; Asgari D; Khani M; Emami M; Moghadam A; Panahi-Bazaz MR; Hosseini Tehrani M; Karimian F; Hosseini B; Nekuie Moghadam T; Hassanpour H; Akbari MT; Elahi E Br J Ophthalmol; 2020 Nov; 104(11):1621-1628. PubMed ID: 31420327 [TBL] [Abstract][Full Text] [Related]
12. Absence of phenotype-genotype correlation of patients expressing mutations in the SLC4A11 gene. Mehta JS; Hemadevi B; Vithana EN; Arunkumar J; Srinivasan M; Prajna V; Tan DT; Aung T; Sundaresan P Cornea; 2010 Mar; 29(3):302-6. PubMed ID: 20118786 [TBL] [Abstract][Full Text] [Related]
13. Detailed assessment of renal function in a proband with Harboyan syndrome caused by a novel homozygous SLC4A11 nonsense mutation. Liskova P; Dudakova L; Tesar V; Bednarova V; Kidorova J; Jirsova K; Davidson AE; Hardcastle AJ Ophthalmic Res; 2015; 53(1):30-5. PubMed ID: 25500497 [TBL] [Abstract][Full Text] [Related]
15. Defective cell adhesion function of solute transporter, SLC4A11, in endothelial corneal dystrophies. Malhotra D; Jung M; Fecher-Trost C; Lovatt M; Peh GSL; Noskov S; Mehta JS; Zimmermann R; Casey JR Hum Mol Genet; 2020 Jan; 29(1):97-116. PubMed ID: 31691803 [TBL] [Abstract][Full Text] [Related]
16. Autosomal recessive corneal endothelial dystrophy (CHED2) is associated with mutations in SLC4A11. Jiao X; Sultana A; Garg P; Ramamurthy B; Vemuganti GK; Gangopadhyay N; Hejtmancik JF; Kannabiran C J Med Genet; 2007 Jan; 44(1):64-8. PubMed ID: 16825429 [TBL] [Abstract][Full Text] [Related]
17. Congenital hereditary endothelial dystrophy - mutation analysis of SLC4A11 and genotype-phenotype correlation in a North Indian patient cohort. Paliwal P; Sharma A; Tandon R; Sharma N; Titiyal JS; Sen S; Nag TC; Vajpayee RB Mol Vis; 2010 Dec; 16():2955-63. PubMed ID: 21203343 [TBL] [Abstract][Full Text] [Related]
18. Mice with a targeted disruption of Slc4a11 model the progressive corneal changes of congenital hereditary endothelial dystrophy. Han SB; Ang HP; Poh R; Chaurasia SS; Peh G; Liu J; Tan DT; Vithana EN; Mehta JS Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6179-89. PubMed ID: 23942972 [TBL] [Abstract][Full Text] [Related]
19. Identification of mutations in the SLC4A11 gene in patients with recessive congenital hereditary endothelial dystrophy. Hemadevi B; Veitia RA; Srinivasan M; Arunkumar J; Prajna NV; Lesaffre C; Sundaresan P Arch Ophthalmol; 2008 May; 126(5):700-8. PubMed ID: 18474783 [TBL] [Abstract][Full Text] [Related]
20. Functional assessment of SLC4A11, an integral membrane protein mutated in corneal dystrophies. Loganathan SK; Schneider HP; Morgan PE; Deitmer JW; Casey JR Am J Physiol Cell Physiol; 2016 Nov; 311(5):C735-C748. PubMed ID: 27558157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]